EX-32.2 11 g24036exv32w2.htm EX-32.2 exv32w2
EXHIBIT 32.2
 
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
 
In connection with this quarterly report on Form 10-Q of King Pharmaceuticals, Inc., I, Joseph Squicciarino, Chief Financial Officer of King Pharmaceuticals, Inc., certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
1. The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in this report fairly presents, in all material respects, the financial condition and results of operations of King Pharmaceuticals, Inc.
 
/s/  JOSEPH SQUICCIARINO
Joseph Squicciarino
Chief Financial Officer
 
Date: August 9, 2010